Latvia vs Switzerland: Proportion of bloodstream infection due to methicillin-resistant
Latvia
3.0%
in 2023
Switzerland
4.0%
in 2023
Latvia rank
51st
Switzerland rank
50th
Proportion of bloodstream infection due to methicillin-resistant over time
- Latvia
- Switzerland
How they compare
Switzerland currently reports 4.0% against 3.0% in Latvia, a difference of 1.0%.
That makes Switzerland's figure about 1.3 times Latvia's.
The two have swapped places 2 times across 8 shared years of data; in 2016 it was Switzerland ahead.
Latvia ranks 51st and Switzerland ranks 50th of 55 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.4% | 4.8% | 0.6% | Latvia |
| 2020s | 6.3% | 4.4% | 1.9% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Latvia or Switzerland?
- Switzerland, at 4.0% against 3.0% in Latvia as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Latvia and Switzerland?
- 1.0%, with Switzerland ahead.
- How many years of comparable data are there for Latvia and Switzerland?
- 8 years are reported by both, from 2016 to 2023.
- How do Latvia and Switzerland rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Latvia ranks 51st and Switzerland ranks 50th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.